Literature review analyzes malignant progression in intraductal papillary mucinous neoplasms, indicating genetic diversity affects treatment approaches.
Key Points
The study identifies distinct genetic profiles in intraductal papillary mucinous neoplasms linked to invasive carcinoma, highlighting their uniqueness.
Key findings from molecular genetic studies in recent decades reveal the challenges in diagnosing associated invasive carcinomas.
Literature review and cancer registry analysis from Moscow emphasize genomic alterations impacting treatment decisions.
Understanding the genetic heterogeneity of IPMNs may help in developing targeted therapies and refining management strategies.